Barinthus Biotherapeutics PLC
NASDAQ:BRNS
Barinthus Biotherapeutics PLC
NASDAQ:BRNS
Price:
0.6
USD
Market Cap:
$24.5m
Income Statement
Earnings Waterfall
Barinthus Biotherapeutics PLC
Barinthus Biotherapeutics PLC
Income Statement
Barinthus Biotherapeutics PLC
Barinthus Biotherapeutics PLC
Currency: USD
| Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||
| Interest Expense |
0
|
0
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Revenue |
4
N/A
|
1
-84%
|
0
-57%
|
15
+5 624%
|
32
+111%
|
39
+19%
|
45
+16%
|
30
-33%
|
13
-55%
|
7
-46%
|
1
-89%
|
0
-58%
|
0
N/A
|
15
N/A
|
15
N/A
|
15
N/A
|
0
N/A
|
|
| Operating Income | ||||||||||||||||||
| Operating Expenses |
(38)
|
(39)
|
(45)
|
(82)
|
(69)
|
(62)
|
(49)
|
(56)
|
(80)
|
(97)
|
(85)
|
(80)
|
(71)
|
(80)
|
(65)
|
(87)
|
(42)
|
|
| Selling, General & Administrative |
(23)
|
(24)
|
(25)
|
(44)
|
(25)
|
(11)
|
(6)
|
(15)
|
(34)
|
(47)
|
(40)
|
(34)
|
(28)
|
(40)
|
(24)
|
(36)
|
(21)
|
|
| Research & Development |
(15)
|
(16)
|
(20)
|
(40)
|
(45)
|
(51)
|
(42)
|
(41)
|
(45)
|
(51)
|
(45)
|
(46)
|
(44)
|
(40)
|
(42)
|
(39)
|
(22)
|
|
| Other Operating Expenses |
0
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
(11)
|
1
|
|
| Operating Income |
(34)
N/A
|
(38)
-12%
|
(45)
-18%
|
(67)
-48%
|
(36)
+46%
|
(23)
+36%
|
(4)
+83%
|
(26)
-548%
|
(66)
-153%
|
(90)
-36%
|
(84)
+7%
|
(79)
+5%
|
(71)
+10%
|
(65)
+9%
|
(50)
+22%
|
(72)
-42%
|
(42)
+41%
|
|
| Pre-Tax Income | ||||||||||||||||||
| Interest Income Expense |
2
|
2
|
4
|
4
|
4
|
4
|
3
|
5
|
5
|
5
|
3
|
2
|
2
|
3
|
3
|
2
|
2
|
|
| Non-Reccuring Items |
(14)
|
(14)
|
(14)
|
(14)
|
(14)
|
(14)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(18)
|
0
|
(17)
|
|
| Total Other Income |
4
|
3
|
4
|
7
|
7
|
6
|
2
|
2
|
2
|
4
|
5
|
4
|
4
|
3
|
4
|
4
|
3
|
|
| Pre-Tax Income |
(42)
N/A
|
(46)
-11%
|
(51)
-10%
|
(70)
-37%
|
(39)
+44%
|
(27)
+31%
|
1
N/A
|
(20)
N/A
|
(59)
-203%
|
(82)
-38%
|
(77)
+6%
|
(73)
+4%
|
(65)
+11%
|
(59)
+10%
|
(61)
-4%
|
(65)
-7%
|
(55)
+16%
|
|
| Net Income | ||||||||||||||||||
| Tax Provision |
(0)
|
(0)
|
0
|
1
|
2
|
2
|
4
|
4
|
4
|
4
|
3
|
3
|
1
|
1
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
(42)
|
(46)
|
(51)
|
(69)
|
(37)
|
(25)
|
5
|
(15)
|
(55)
|
(77)
|
(73)
|
(71)
|
(64)
|
(58)
|
(61)
|
(65)
|
(55)
|
|
| Income to Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Net Income (Common) |
(41)
N/A
|
(46)
-11%
|
(51)
-10%
|
(69)
-35%
|
(37)
+46%
|
(24)
+34%
|
5
N/A
|
(15)
N/A
|
(55)
-256%
|
(77)
-41%
|
(73)
+5%
|
(71)
+4%
|
(64)
+10%
|
(58)
+9%
|
(61)
-6%
|
(65)
-7%
|
(55)
+16%
|
|
| EPS (Diluted) |
-1.21
N/A
|
-1.35
-12%
|
-1.37
-1%
|
-1.79
-31%
|
-0.97
+46%
|
-0.63
+35%
|
0.14
N/A
|
-0.42
N/A
|
-1.45
-245%
|
-2
-38%
|
-1.91
+5%
|
-1.83
+4%
|
-1.65
+10%
|
-1.46
+12%
|
-1.55
-6%
|
-1.64
-6%
|
-1.36
+17%
|
|
Switch to:
Switch to:
See Also
Discover More
